BCG
JNJ icon

Bravias Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bravias Capital Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,520
Closed -$315K – 105
2025
Q4 		$315K Buy
1,520
+220
+17% +$43.5K 0.19% 86
2025
Q3 		$241K Buy
+1,300
New +$223K 0.16% 91

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bravias Capital Group's JNJ Position: Q1 2026 in Review

Bravias Capital Group sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,520 shares — an estimated $315K sold.

Bravias Capital Group first reported a position in JNJ in Q3 2025 and held it in 2 quarters. The position peaked at $315K in Q4 2025. 4,619 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Bravias Capital Group reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Bravias Capital Group sold 1,520 Johnson & Johnson shares in Q1 2026, an estimated $315K.
  • Bravias Capital Group first reported a position in Johnson & Johnson in Q3 2025 and held it in 2 quarters.
  • Bravias Capital Group's Johnson & Johnson position peaked at $315K in Q4 2025.
  • 4,619 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Bravias Capital Group's 13F filing for Q1 2026, filed 28 Apr 2026.